Entrada Therapeutics (NASDAQ:TRDA – Get Free Report) and Immuneering (NASDAQ:IMRX – Get Free Report) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, dividends, institutional ownership, profitability, valuation, analyst recommendations and risk. Insider and Institutional Ownership 86.4% of Entrada Therapeutics […]